chr3-51989026-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000666.3(ACY1):​c.1178G>A​(p.Arg393His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00411 in 1,614,040 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 12 hom. )

Consequence

ACY1
NM_000666.3 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:4

Conservation

PhyloP100: 0.0930
Variant links:
Genes affected
ACY1 (HGNC:177): (aminoacylase 1) This gene encodes a cytosolic, homodimeric, zinc-binding enzyme that catalyzes the hydrolysis of acylated L-amino acids to L-amino acids and an acyl group, and has been postulated to function in the catabolism and salvage of acylated amino acids. This gene is located on chromosome 3p21.1, a region reduced to homozygosity in small-cell lung cancer (SCLC), and its expression has been reported to be reduced or undetectable in SCLC cell lines and tumors. The amino acid sequence of human aminoacylase-1 is highly homologous to the porcine counterpart, and this enzyme is the first member of a new family of zinc-binding enzymes. Mutations in this gene cause aminoacylase-1 deficiency, a metabolic disorder characterized by central nervous system defects and increased urinary excretion of N-acetylated amino acids. Alternative splicing of this gene results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream ABHD14A (abhydrolase domain containing 14A) gene, as represented in GeneID:100526760. A related pseudogene has been identified on chromosome 18. [provided by RefSeq, Nov 2010]
ABHD14A-ACY1 (HGNC:38856): (ABHD14A-ACY1 readthrough) This locus represents naturally occurring read-through transcription between the neighboring abhydrolase domain containing 14A (ABHD14A) and aminoacylase 1 (ACY1) genes on chromosome 3. The read-through transcript encodes a protein that shares sequence identity with the downstream gene product but its N-terminal region is distinct due to the use of an alternate start codon relative to the upstream gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06689611).
BP6
Variant 3-51989026-G-A is Benign according to our data. Variant chr3-51989026-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 18114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00336 (512/152260) while in subpopulation NFE AF= 0.00557 (379/68022). AF 95% confidence interval is 0.00511. There are 1 homozygotes in gnomad4. There are 230 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACY1NM_000666.3 linkc.1178G>A p.Arg393His missense_variant Exon 15 of 15 ENST00000636358.2 NP_000657.1 Q03154-1V9HWA0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACY1ENST00000636358.2 linkc.1178G>A p.Arg393His missense_variant Exon 15 of 15 1 NM_000666.3 ENSP00000490149.1 Q03154-1
ABHD14A-ACY1ENST00000463937.1 linkc.1481G>A p.Arg494His missense_variant Exon 16 of 16 5 ENSP00000420487.1 C9JMV9

Frequencies

GnomAD3 genomes
AF:
0.00337
AC:
512
AN:
152142
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000869
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00396
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00557
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00367
AC:
921
AN:
250836
Hom.:
3
AF XY:
0.00363
AC XY:
492
AN XY:
135608
show subpopulations
Gnomad AFR exome
AF:
0.000555
Gnomad AMR exome
AF:
0.00150
Gnomad ASJ exome
AF:
0.00666
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.00509
Gnomad NFE exome
AF:
0.00567
Gnomad OTH exome
AF:
0.00424
GnomAD4 exome
AF:
0.00419
AC:
6127
AN:
1461780
Hom.:
12
Cov.:
32
AF XY:
0.00399
AC XY:
2905
AN XY:
727188
show subpopulations
Gnomad4 AFR exome
AF:
0.000717
Gnomad4 AMR exome
AF:
0.00152
Gnomad4 ASJ exome
AF:
0.00754
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.000336
Gnomad4 FIN exome
AF:
0.00563
Gnomad4 NFE exome
AF:
0.00473
Gnomad4 OTH exome
AF:
0.00392
GnomAD4 genome
AF:
0.00336
AC:
512
AN:
152260
Hom.:
1
Cov.:
32
AF XY:
0.00309
AC XY:
230
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.000867
Gnomad4 AMR
AF:
0.00137
Gnomad4 ASJ
AF:
0.00778
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00396
Gnomad4 NFE
AF:
0.00557
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00485
Hom.:
4
Bravo
AF:
0.00296
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00397
AC:
482
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00589
EpiControl
AF:
0.00634

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ABHD14A-ACY1: BP4 -

Aminoacylase 1 deficiency Pathogenic:1
Jun 12, 2007
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

not specified Benign:1
Jun 14, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

ACY1-related disorder Benign:1
Feb 10, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.22
.;T;.;.;.;T;.
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.80
T;.;T;T;T;T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.067
T;T;T;T;T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
0.47
.;N;.;.;.;N;.
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.4
N;.;N;N;N;N;.
REVEL
Uncertain
0.32
Sift
Benign
0.27
T;.;D;D;T;D;.
Sift4G
Benign
0.18
T;.;T;T;T;T;.
Polyphen
0.99
.;D;.;.;.;D;.
Vest4
0.71
MVP
0.41
MPC
0.62
ClinPred
0.043
T
GERP RS
-0.98
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.18
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121912701; hg19: chr3-52023042; API